All articles by GlobalData Healthcare
GlobalData Healthcare
Early detection of lung cancer is essential in curtailing lung cancer mortality
Estimated annual lung cancer deaths are projected to increase by 50% to more than three million deaths by 2040.
Medical Devices and Their Environmental Impact
According to a recent poll by GlobalData, despite the challenges the industry faces, the medical device field is not doing enough to be more environmentally sustainable.
Psychiatry opts for the use of precision medicine AI models
Precision medicine uses biomarkers, data analytics and artificial intelligence to provide personalised treatment projections.
Tele-mentoring used to improve surgical robotic systems training
Telemedicine involves the exchange of medical information from one site to another through the use of electronic communication.
NeuroPace neurostimulation system under trials
While NeuroPace’s technology is far from a market launch, it is the only FDA-approved brain-responsive neurostimulation system.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
ScanNav anatomy PNB receives FDA clearance
ScanNav Anatomy PNB is designed to enhance ultrasound imaging through a colour overlay of key sono-anatomical structures.
Regulating medical devices with AI capabilities
AI can improve the quality of many medical devices, but its increasing use raises questions surrounding regulation.
Covid-19 pandemic milked dry? Major players shifting away from Covid-19 testing
Demand for Covid-19 testing is expected to drop further into next year as people are able to access vaccines more easily.
Development of automated insulin delivery systems simplifies diabetes management
Automated insulin delivery systems allow uninterrupted communication between a continuous glucose monitor (CGM) and insulin pump.
New features released by Microsoft add to growing healthcare Cloud computing industry
GlobalData expects global spending on Cloud services such as Microsoft Cloud for Healthcare to reach $429.4bn by the end of 2024.